SXTP

60 Degrees Pharmaceuticals, Inc. Common Stock

0.54

USD

SXTP Earnings Reports

Positive Surprise Ratio

SXTP beat 2 of 9 last estimates.

22%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -1 (Revenue/ EPS)

60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, SXTP reported earnings of -0.66 USD per share (EPS) for Q3 25, beating the estimate of -1.23 USD, resulting in a 46.52% surprise. Revenue reached 528.56 thousand, compared to an expected 408.00 thousand, with a 29.55% difference. The market reacted with a -4.88% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were 60 Degrees Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$0.66, beating estimates by 46.52%, and revenue of $528.56K, 29.55% above expectations.

How did the market react to 60 Degrees Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -4.88%, changed from $1.23 before the earnings release to $1.17 the day after.

When is 60 Degrees Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for 60 Degrees Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on -- analysts, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.